BRAINSTORM CELL THERAPEUTICS INC. short interest in 2025

In 2025, BRAINSTORM CELL THERAPEUTICS INC.'s disclosed short interest ran from 2.10% of shares outstanding on 31 Mar 2025 to 8.68% on 15 Jul 2025, a change of +6.58 percentage points. The year's high was 9.27% on 30 Jun 2025 and its low 2.10% on 31 Mar 2025, averaging 5.80% across 6 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 2.94 days on 31 Mar 2025. Full history: BRAINSTORM CELL THERAPEUTICS INC..

Cite this page

Plain

Short position data for BRAINSTORM CELL THERAPEUTICS INC. short interest in 2025: FINRA, compiled by howshorted.com, settlement date 15 Jul 2025. https://howshorted.com/us/company/bcli/2025/

Wikipedia

<ref>{{cite web |title=BRAINSTORM CELL THERAPEUTICS INC. short interest in 2025 short position data |url=https://howshorted.com/us/company/bcli/2025/ |website=HowShorted |publisher=howshorted.com (data: FINRA) |date=2025-07-15 |access-date=2026-10-13}}</ref>

BibTeX

@misc{howshorted-brainstorm-cell-therapeutics-inc-short-i-2025-07-15,
  title        = {BRAINSTORM CELL THERAPEUTICS INC. short interest in 2025 short position data},
  author       = {{HowShorted}},
  howpublished = {\url{https://howshorted.com/us/company/bcli/2025/}},
  note         = {Data: FINRA, settlement date 15 Jul 2025; accessed 2026-10-13},
  year         = {2025}
}

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025

2025 in figures

Start of year: 2.10% (31 Mar 2025)
End of year: 8.68% (15 Jul 2025)
Change: +6.58 pp
High: 9.27% (30 Jun 2025)
Low: 2.10% (31 Mar 2025)
Average: 5.80%
Highest days to cover: 2.94 (31 Mar 2025)
SEC filings marked: 8

Every report in 2025

BRAINSTORM CELL THERAPEUTICS INC. short interest in 2025
Settlement	Short interest	Days to cover	Filings since previous
31 Mar 2025	2.10%	2.94	10-K filed, results (8-K)
30 Apr 2025	4.47%	1.85
15 May 2025	3.21%	1.78	10-Q filed, results (8-K)
13 Jun 2025	7.10%	1.08
30 Jun 2025	9.27%	1.34
15 Jul 2025	8.68%	1.34

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.